134 related articles for article (PubMed ID: 33823404)
1. Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists.
Wang S; Ren J; Li R; Li X; Zhangsun D; Wu Y; Luo S
Bioorg Chem; 2021 Jul; 112():104875. PubMed ID: 33823404
[TBL] [Abstract][Full Text] [Related]
2. α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors.
Wu Y; Zhangsun D; Zhu X; Kaas Q; Zhangsun M; Harvey PJ; Craik DJ; McIntosh JM; Luo S
J Med Chem; 2017 Jul; 60(13):5826-5833. PubMed ID: 28603989
[TBL] [Abstract][Full Text] [Related]
3. Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor.
Ren J; Li R; Ning J; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29925760
[TBL] [Abstract][Full Text] [Related]
4. α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice.
Li X; You S; Xiong J; Qiao Y; Yu J; Zhangsun D; Luo S
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339145
[TBL] [Abstract][Full Text] [Related]
5. Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.
Yu J; Zhu X; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2018 Oct; 61(20):9256-9265. PubMed ID: 30252466
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors.
Luo S; Zhangsun D; Zhu X; Wu Y; Hu Y; Christensen S; Harvey PJ; Akcan M; Craik DJ; McIntosh JM
J Med Chem; 2013 Dec; 56(23):9655-63. PubMed ID: 24200193
[TBL] [Abstract][Full Text] [Related]
7. Fluorescently Labeled α-Conotoxin TxID, a New Probe for α3β4 Neuronal Nicotinic Acetylcholine Receptors.
Huang M; Zhu X; Yang Y; Tan Y; Luo S; Zhangsun D
Mar Drugs; 2022 Aug; 20(8):. PubMed ID: 36005514
[TBL] [Abstract][Full Text] [Related]
8. Loop2 Size Modification Reveals Significant Impacts on the Potency of α-Conotoxin TxID.
Dong J; Zhang P; Xie J; Xie T; Zhu X; Zhangsun D; Yu J; Luo S
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233480
[TBL] [Abstract][Full Text] [Related]
9. Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.
Grishin AA; Wang CI; Muttenthaler M; Alewood PF; Lewis RJ; Adams DJ
J Biol Chem; 2010 Jul; 285(29):22254-63. PubMed ID: 20466726
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a potent and selective α3β4 nicotinic acetylcholine receptor antagonist from an α-conotoxin synthetic combinatorial library.
Chang YP; Banerjee J; Dowell C; Wu J; Gyanda R; Houghten RA; Toll L; McIntosh JM; Armishaw CJ
J Med Chem; 2014 Apr; 57(8):3511-21. PubMed ID: 24649848
[TBL] [Abstract][Full Text] [Related]
11. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
[TBL] [Abstract][Full Text] [Related]
12. Solving the alpha-conotoxin folding problem: efficient selenium-directed on-resin generation of more potent and stable nicotinic acetylcholine receptor antagonists.
Muttenthaler M; Nevin ST; Grishin AA; Ngo ST; Choy PT; Daly NL; Hu SH; Armishaw CJ; Wang CI; Lewis RJ; Martin JL; Noakes PG; Craik DJ; Adams DJ; Alewood PF
J Am Chem Soc; 2010 Mar; 132(10):3514-22. PubMed ID: 20163143
[TBL] [Abstract][Full Text] [Related]
13. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
[TBL] [Abstract][Full Text] [Related]
14. A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists.
Armishaw CJ; Singh N; Medina-Franco JL; Clark RJ; Scott KC; Houghten RA; Jensen AA
J Biol Chem; 2010 Jan; 285(3):1809-21. PubMed ID: 19901032
[TBL] [Abstract][Full Text] [Related]
15. Cysteine [2,4] Disulfide Bond as a New Modifiable Site of α-Conotoxin TxIB.
Zhang B; Ren M; Xiong Y; Li H; Wu Y; Fu Y; Zhangsun D; Dong S; Luo S
Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33671487
[TBL] [Abstract][Full Text] [Related]
16. Structure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA.
Xu P; Kaas Q; Wu Y; Zhu X; Li X; Harvey PJ; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2020 Feb; 63(4):1564-1575. PubMed ID: 31986036
[TBL] [Abstract][Full Text] [Related]
17. Improving the stability of α-conotoxin AuIB through N-to-C cyclization: the effect of linker length on stability and activity at nicotinic acetylcholine receptors.
Armishaw CJ; Jensen AA; Balle LD; Scott KC; Sørensen L; Strømgaard K
Antioxid Redox Signal; 2011 Jan; 14(1):65-76. PubMed ID: 20649464
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors.
Inserra MC; Kompella SN; Vetter I; Brust A; Daly NL; Cuny H; Craik DJ; Alewood PF; Adams DJ; Lewis RJ
Biochem Pharmacol; 2013 Sep; 86(6):791-9. PubMed ID: 23924607
[TBL] [Abstract][Full Text] [Related]
19. Effects of Cyclization on Activity and Stability of α-Conotoxin TxIB.
Li X; Wang S; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32235388
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies on alpha-conotoxins.
Muttenthaler M; Akondi KB; Alewood PF
Curr Pharm Des; 2011 Dec; 17(38):4226-41. PubMed ID: 22204424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
